ParkinsonCanadaV1, PascalFrancis, Curation, bibRecord, 000229

Adenosine receptors and Parkinson's disease: Relevance of antagonistic adenosine and dopamine receptor interactions in the striatum

Identifieur interne : 000229 ( PascalFrancis/Curation ); précédent : 000228; suivant : 000230

Adenosine receptors and Parkinson's disease: Relevance of antagonistic adenosine and dopamine receptor interactions in the striatum

Auteurs : Kjell Fuxe [Suède] ; Ingrid Strömberg [Suède] ; Patrizia Popoli [Italie] ; Roberto Rimondini-Giorgini [Suède] ; Maria Torvinen [Suède] ; Sven O. Ögren [Suède] ; Rafael Franco [Espagne] ; Luigi F. Agnati [Italie] ; Sergi Ferre [Suède]

Source :

Advances in neurology [ 0091-3952 ] ; 2001.

RBID : Pascal:03-0237959

Descripteurs français

Pascal (Inist)
- Parkinson maladie, Récepteur adénosinique, Récepteur dopaminergique, Interaction, Homme.
Wicri :
- topic : Homme.

English descriptors

KwdEn :
- Adenosine receptor, Dopamine receptor, Human, Interaction, Parkinson disease.

A01	`01`	`1`		`@0 0091-3952`
A02	`01`			`@0 ADNRA3`
A03		`1`		`@0 Adv. neurol.`
A05				`@2 86`
A08	`01`	`1`	`ENG`	`@1 Adenosine receptors and Parkinson's disease: Relevance of antagonistic adenosine and dopamine receptor interactions in the striatum`
A09	`01`	`1`	`ENG`	`@1 Parkinson's disease`
A11	`01`	`1`		`@1 FUXE (Kjell)`
A11	`02`	`1`		`@1 STRÖMBERG (Ingrid)`
A11	`03`	`1`		`@1 POPOLI (Patrizia)`
A11	`04`	`1`		`@1 RIMONDINI-GIORGINI (Roberto)`
A11	`05`	`1`		`@1 TORVINEN (Maria)`
A11	`06`	`1`		`@1 ÖGREN (Sven O.)`
A11	`07`	`1`		`@1 FRANCO (Rafael)`
A11	`08`	`1`		`@1 AGNATI (Luigi F.)`
A11	`09`	`1`		`@1 FERRE (Sergi)`
A12	`01`	`1`		`@1 CALNE (Donald) @9 ed.`
A12	`02`	`1`		`@1 CALNE (Susan M.) @9 ed.`
A14	`01`			`@1 Department of Neuroscience, Division of Cellular and Molecular Neurochemistry, Karolinska Institute @2 17177 Stockholm @3 SWE @Z 1 aut. @Z 2 aut. @Z 4 aut. @Z 5 aut. @Z 6 aut. @Z 9 aut.`
A14	`02`			`@1 Department of Pharmacology. Istituto Superiore de Sanità @2 00161 Rome @3 ITA @Z 3 aut.`
A14	`03`			`@1 Department of Biochemistry and Molecular Biology, Faculty of Chemistry, University of Barcelona @2 08028 Barcelona @3 ESP @Z 7 aut.`
A14	`04`			`@1 Department of Human Physiology, University of Modena @2 41100 Modena @3 ITA @Z 8 aut.`
A15	`01`			`@1 Neurodegenerative Disorders Centre, University of British Columbia, Vancouver Hospital and Health Sciences Center, Purdy Pavillon @2 Vancouver, British Columbia @3 CAN @Z 1 aut. @Z 2 aut.`
A18	`01`	`1`		`@1 World Federation of Neurology Research Committee on "Parkinsonism and Related Disorders" @3 INC @9 patr.`
A18	`02`	`1`		`@1 Pacific Parkinsons Research Institute @3 CAN @9 patr.`
A20				`@1 345-353`
A21				`@1 2001`
A23	`01`			`@0 ENG`
A43	`01`			`@1 INIST @2 15741 @5 354000109446770350`
A44				`@0 0000 @1 © 2003 INIST-CNRS. All rights reserved.`
A45				`@0 40 ref.`
A47	`01`	`1`		`@0 03-0237959`
A60				`@1 P @2 C`
A61				`@0 A`
A64	`01`	`1`		`@0 Advances in neurology`
A66	`01`			`@0 USA`
C02	`01`	`X`		`@0 002B17G`
C03	`01`	`X`	`FRE`	`@0 Parkinson maladie @5 01`
C03	`01`	`X`	`ENG`	`@0 Parkinson disease @5 01`
C03	`01`	`X`	`SPA`	`@0 Parkinson enfermedad @5 01`
C03	`02`	`X`	`FRE`	`@0 Récepteur adénosinique @5 17`
C03	`02`	`X`	`ENG`	`@0 Adenosine receptor @5 17`
C03	`02`	`X`	`SPA`	`@0 Receptor adenosínico @5 17`
C03	`03`	`X`	`FRE`	`@0 Récepteur dopaminergique @5 18`
C03	`03`	`X`	`ENG`	`@0 Dopamine receptor @5 18`
C03	`03`	`X`	`SPA`	`@0 Receptor dopaminérgico @5 18`
C03	`04`	`X`	`FRE`	`@0 Interaction @5 19`
C03	`04`	`X`	`ENG`	`@0 Interaction @5 19`
C03	`04`	`X`	`SPA`	`@0 Interacción @5 19`
C03	`05`	`X`	`FRE`	`@0 Homme @5 20`
C03	`05`	`X`	`ENG`	`@0 Human @5 20`
C03	`05`	`X`	`SPA`	`@0 Hombre @5 20`
C07	`01`	`X`	`FRE`	`@0 Encéphale pathologie @5 37`
C07	`01`	`X`	`ENG`	`@0 Cerebral disorder @5 37`
C07	`01`	`X`	`SPA`	`@0 Encéfalo patología @5 37`
C07	`02`	`X`	`FRE`	`@0 Extrapyramidal syndrome @5 38`
C07	`02`	`X`	`ENG`	`@0 Extrapyramidal syndrome @5 38`
C07	`02`	`X`	`SPA`	`@0 Extrapiramidal síndrome @5 38`
C07	`03`	`X`	`FRE`	`@0 Maladie dégénérative @5 39`
C07	`03`	`X`	`ENG`	`@0 Degenerative disease @5 39`
C07	`03`	`X`	`SPA`	`@0 Enfermedad degenerativa @5 39`
C07	`04`	`X`	`FRE`	`@0 Système nerveux central pathologie @5 40`
C07	`04`	`X`	`ENG`	`@0 Central nervous system disease @5 40`
C07	`04`	`X`	`SPA`	`@0 Sistema nervosio central patología @5 40`
C07	`05`	`X`	`FRE`	`@0 Système nerveux pathologie @5 41`
C07	`05`	`X`	`ENG`	`@0 Nervous system diseases @5 41`
C07	`05`	`X`	`SPA`	`@0 Sistema nervioso patología @5 41`
N21				`@1 146`
N82				`@1 PSI`

A30	`01`	`1`	`ENG`	`@1 Parkinson's Disease. International Congress @3 Vancouver CAN @4 1999-07-25`

Links toward previous steps (curation, corpus...)

to stream PascalFrancis, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000A94

Links to Exploration step

Pascal:03-0237959

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Adenosine receptors and Parkinson's disease: Relevance of antagonistic adenosine and dopamine receptor interactions in the striatum</title>
<author><name sortKey="Fuxe, Kjell" sort="Fuxe, Kjell" uniqKey="Fuxe K" first="Kjell" last="Fuxe">Kjell Fuxe</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Neuroscience, Division of Cellular and Molecular Neurochemistry, Karolinska Institute</s1>
<s2>17177 Stockholm</s2>
<s3>SWE</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
<country>Suède</country>
</affiliation>
</author>
<author><name sortKey="Stromberg, Ingrid" sort="Stromberg, Ingrid" uniqKey="Stromberg I" first="Ingrid" last="Strömberg">Ingrid Strömberg</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Neuroscience, Division of Cellular and Molecular Neurochemistry, Karolinska Institute</s1>
<s2>17177 Stockholm</s2>
<s3>SWE</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
<country>Suède</country>
</affiliation>
</author>
<author><name sortKey="Popoli, Patrizia" sort="Popoli, Patrizia" uniqKey="Popoli P" first="Patrizia" last="Popoli">Patrizia Popoli</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Department of Pharmacology. Istituto Superiore de Sanità</s1>
<s2>00161 Rome</s2>
<s3>ITA</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Italie</country>
</affiliation>
</author>
<author><name sortKey="Rimondini Giorgini, Roberto" sort="Rimondini Giorgini, Roberto" uniqKey="Rimondini Giorgini R" first="Roberto" last="Rimondini-Giorgini">Roberto Rimondini-Giorgini</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Neuroscience, Division of Cellular and Molecular Neurochemistry, Karolinska Institute</s1>
<s2>17177 Stockholm</s2>
<s3>SWE</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
<country>Suède</country>
</affiliation>
</author>
<author><name sortKey="Torvinen, Maria" sort="Torvinen, Maria" uniqKey="Torvinen M" first="Maria" last="Torvinen">Maria Torvinen</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Neuroscience, Division of Cellular and Molecular Neurochemistry, Karolinska Institute</s1>
<s2>17177 Stockholm</s2>
<s3>SWE</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
<country>Suède</country>
</affiliation>
</author>
<author><name sortKey="Ogren, Sven O" sort="Ogren, Sven O" uniqKey="Ogren S" first="Sven O." last="Ögren">Sven O. Ögren</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Neuroscience, Division of Cellular and Molecular Neurochemistry, Karolinska Institute</s1>
<s2>17177 Stockholm</s2>
<s3>SWE</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
<country>Suède</country>
</affiliation>
</author>
<author><name sortKey="Franco, Rafael" sort="Franco, Rafael" uniqKey="Franco R" first="Rafael" last="Franco">Rafael Franco</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Department of Biochemistry and Molecular Biology, Faculty of Chemistry, University of Barcelona</s1>
<s2>08028 Barcelona</s2>
<s3>ESP</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Espagne</country>
</affiliation>
</author>
<author><name sortKey="Agnati, Luigi F" sort="Agnati, Luigi F" uniqKey="Agnati L" first="Luigi F." last="Agnati">Luigi F. Agnati</name>
<affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Department of Human Physiology, University of Modena</s1>
<s2>41100 Modena</s2>
<s3>ITA</s3>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>Italie</country>
</affiliation>
</author>
<author><name sortKey="Ferre, Sergi" sort="Ferre, Sergi" uniqKey="Ferre S" first="Sergi" last="Ferre">Sergi Ferre</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Neuroscience, Division of Cellular and Molecular Neurochemistry, Karolinska Institute</s1>
<s2>17177 Stockholm</s2>
<s3>SWE</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
<country>Suède</country>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">03-0237959</idno>
<date when="2001">2001</date>
<idno type="stanalyst">PASCAL 03-0237959 INIST</idno>
<idno type="RBID">Pascal:03-0237959</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000A94</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000229</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Adenosine receptors and Parkinson's disease: Relevance of antagonistic adenosine and dopamine receptor interactions in the striatum</title>
<author><name sortKey="Fuxe, Kjell" sort="Fuxe, Kjell" uniqKey="Fuxe K" first="Kjell" last="Fuxe">Kjell Fuxe</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Neuroscience, Division of Cellular and Molecular Neurochemistry, Karolinska Institute</s1>
<s2>17177 Stockholm</s2>
<s3>SWE</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
<country>Suède</country>
</affiliation>
</author>
<author><name sortKey="Stromberg, Ingrid" sort="Stromberg, Ingrid" uniqKey="Stromberg I" first="Ingrid" last="Strömberg">Ingrid Strömberg</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Neuroscience, Division of Cellular and Molecular Neurochemistry, Karolinska Institute</s1>
<s2>17177 Stockholm</s2>
<s3>SWE</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
<country>Suède</country>
</affiliation>
</author>
<author><name sortKey="Popoli, Patrizia" sort="Popoli, Patrizia" uniqKey="Popoli P" first="Patrizia" last="Popoli">Patrizia Popoli</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Department of Pharmacology. Istituto Superiore de Sanità</s1>
<s2>00161 Rome</s2>
<s3>ITA</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Italie</country>
</affiliation>
</author>
<author><name sortKey="Rimondini Giorgini, Roberto" sort="Rimondini Giorgini, Roberto" uniqKey="Rimondini Giorgini R" first="Roberto" last="Rimondini-Giorgini">Roberto Rimondini-Giorgini</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Neuroscience, Division of Cellular and Molecular Neurochemistry, Karolinska Institute</s1>
<s2>17177 Stockholm</s2>
<s3>SWE</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
<country>Suède</country>
</affiliation>
</author>
<author><name sortKey="Torvinen, Maria" sort="Torvinen, Maria" uniqKey="Torvinen M" first="Maria" last="Torvinen">Maria Torvinen</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Neuroscience, Division of Cellular and Molecular Neurochemistry, Karolinska Institute</s1>
<s2>17177 Stockholm</s2>
<s3>SWE</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
<country>Suède</country>
</affiliation>
</author>
<author><name sortKey="Ogren, Sven O" sort="Ogren, Sven O" uniqKey="Ogren S" first="Sven O." last="Ögren">Sven O. Ögren</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Neuroscience, Division of Cellular and Molecular Neurochemistry, Karolinska Institute</s1>
<s2>17177 Stockholm</s2>
<s3>SWE</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
<country>Suède</country>
</affiliation>
</author>
<author><name sortKey="Franco, Rafael" sort="Franco, Rafael" uniqKey="Franco R" first="Rafael" last="Franco">Rafael Franco</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Department of Biochemistry and Molecular Biology, Faculty of Chemistry, University of Barcelona</s1>
<s2>08028 Barcelona</s2>
<s3>ESP</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Espagne</country>
</affiliation>
</author>
<author><name sortKey="Agnati, Luigi F" sort="Agnati, Luigi F" uniqKey="Agnati L" first="Luigi F." last="Agnati">Luigi F. Agnati</name>
<affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Department of Human Physiology, University of Modena</s1>
<s2>41100 Modena</s2>
<s3>ITA</s3>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>Italie</country>
</affiliation>
</author>
<author><name sortKey="Ferre, Sergi" sort="Ferre, Sergi" uniqKey="Ferre S" first="Sergi" last="Ferre">Sergi Ferre</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Neuroscience, Division of Cellular and Molecular Neurochemistry, Karolinska Institute</s1>
<s2>17177 Stockholm</s2>
<s3>SWE</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
<country>Suède</country>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Advances in neurology</title>
<title level="j" type="abbreviated">Adv. neurol.</title>
<idno type="ISSN">0091-3952</idno>
<imprint><date when="2001">2001</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Advances in neurology</title>
<title level="j" type="abbreviated">Adv. neurol.</title>
<idno type="ISSN">0091-3952</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adenosine receptor</term>
<term>Dopamine receptor</term>
<term>Human</term>
<term>Interaction</term>
<term>Parkinson disease</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Parkinson maladie</term>
<term>Récepteur adénosinique</term>
<term>Récepteur dopaminergique</term>
<term>Interaction</term>
<term>Homme</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0091-3952</s0>
</fA01>
<fA02 i1="01"><s0>ADNRA3</s0>
</fA02>
<fA03 i2="1"><s0>Adv. neurol.</s0>
</fA03>
<fA05><s2>86</s2>
</fA05>
<fA08 i1="01" i2="1" l="ENG"><s1>Adenosine receptors and Parkinson's disease: Relevance of antagonistic adenosine and dopamine receptor interactions in the striatum</s1>
</fA08>
<fA09 i1="01" i2="1" l="ENG"><s1>Parkinson's disease</s1>
</fA09>
<fA11 i1="01" i2="1"><s1>FUXE (Kjell)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>STRÖMBERG (Ingrid)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>POPOLI (Patrizia)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>RIMONDINI-GIORGINI (Roberto)</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>TORVINEN (Maria)</s1>
</fA11>
<fA11 i1="06" i2="1"><s1>ÖGREN (Sven O.)</s1>
</fA11>
<fA11 i1="07" i2="1"><s1>FRANCO (Rafael)</s1>
</fA11>
<fA11 i1="08" i2="1"><s1>AGNATI (Luigi F.)</s1>
</fA11>
<fA11 i1="09" i2="1"><s1>FERRE (Sergi)</s1>
</fA11>
<fA12 i1="01" i2="1"><s1>CALNE (Donald)</s1>
<s9>ed.</s9>
</fA12>
<fA12 i1="02" i2="1"><s1>CALNE (Susan M.)</s1>
<s9>ed.</s9>
</fA12>
<fA14 i1="01"><s1>Department of Neuroscience, Division of Cellular and Molecular Neurochemistry, Karolinska Institute</s1>
<s2>17177 Stockholm</s2>
<s3>SWE</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>9 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>Department of Pharmacology. Istituto Superiore de Sanità</s1>
<s2>00161 Rome</s2>
<s3>ITA</s3>
<sZ>3 aut.</sZ>
</fA14>
<fA14 i1="03"><s1>Department of Biochemistry and Molecular Biology, Faculty of Chemistry, University of Barcelona</s1>
<s2>08028 Barcelona</s2>
<s3>ESP</s3>
<sZ>7 aut.</sZ>
</fA14>
<fA14 i1="04"><s1>Department of Human Physiology, University of Modena</s1>
<s2>41100 Modena</s2>
<s3>ITA</s3>
<sZ>8 aut.</sZ>
</fA14>
<fA15 i1="01"><s1>Neurodegenerative Disorders Centre, University of British Columbia, Vancouver Hospital and Health Sciences Center, Purdy Pavillon</s1>
<s2>Vancouver, British Columbia</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</fA15>
<fA18 i1="01" i2="1"><s1>World Federation of Neurology Research Committee on "Parkinsonism and Related Disorders"</s1>
<s3>INC</s3>
<s9>patr.</s9>
</fA18>
<fA18 i1="02" i2="1"><s1>Pacific Parkinsons Research Institute</s1>
<s3>CAN</s3>
<s9>patr.</s9>
</fA18>
<fA20><s1>345-353</s1>
</fA20>
<fA21><s1>2001</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>15741</s2>
<s5>354000109446770350</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2003 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>40 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>03-0237959</s0>
</fA47>
<fA60><s1>P</s1>
<s2>C</s2>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Advances in neurology</s0>
</fA64>
<fA66 i1="01"><s0>USA</s0>
</fA66>
<fC02 i1="01" i2="X"><s0>002B17G</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Parkinson maladie</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Parkinson disease</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Parkinson enfermedad</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Récepteur adénosinique</s0>
<s5>17</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Adenosine receptor</s0>
<s5>17</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Receptor adenosínico</s0>
<s5>17</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Récepteur dopaminergique</s0>
<s5>18</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Dopamine receptor</s0>
<s5>18</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Receptor dopaminérgico</s0>
<s5>18</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Interaction</s0>
<s5>19</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Interaction</s0>
<s5>19</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Interacción</s0>
<s5>19</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Homme</s0>
<s5>20</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Human</s0>
<s5>20</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Hombre</s0>
<s5>20</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Encéphale pathologie</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Cerebral disorder</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Encéfalo patología</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Extrapyramidal syndrome</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Extrapyramidal syndrome</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Extrapiramidal síndrome</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Maladie dégénérative</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Degenerative disease</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Enfermedad degenerativa</s0>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Système nerveux central pathologie</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Central nervous system disease</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Sistema nervosio central patología</s0>
<s5>40</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE"><s0>Système nerveux pathologie</s0>
<s5>41</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG"><s0>Nervous system diseases</s0>
<s5>41</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA"><s0>Sistema nervioso patología</s0>
<s5>41</s5>
</fC07>
<fN21><s1>146</s1>
</fN21>
<fN82><s1>PSI</s1>
</fN82>
</pA>
<pR><fA30 i1="01" i2="1" l="ENG"><s1>Parkinson's Disease. International Congress</s1>
<s3>Vancouver CAN</s3>
<s4>1999-07-25</s4>
</fA30>
</pR>
</standard>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/PascalFrancis/Curation

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000229 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Curation/biblio.hfd -nk 000229 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    PascalFrancis
   |étape=   Curation
   |type=    RBID
   |clé=     Pascal:03-0237959
   |texte=   Adenosine receptors and Parkinson's disease: Relevance of antagonistic adenosine and dopamine receptor interactions in the striatum
}}

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022

	La maladie de Parkinson au Canada (serveur d'exploration)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

La maladie de Parkinson au Canada (serveur d'exploration)

Adenosine receptors and Parkinson's disease: Relevance of antagonistic adenosine and dopamine receptor interactions in the striatum

Adenosine receptors and Parkinson's disease: Relevance of antagonistic adenosine and dopamine receptor interactions in the striatum

Source :

Descripteurs français

English descriptors

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri